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Patients’ and clinicians’ perspectives on relevant
treatment outcomes in depression:
qualitative study
Kaying Kan, Frederike Jörg, Erik Buskens, Robert A. Schoevers and Manna A. Alma
Background
Although symptomatic remission is considered the optimal
outcome in depression, this is not always achieved.
Furthermore, symptom indicators do not fully capture patients’
and clinicians’ perspectives on remission. Broader indicators of
(partial) remission from depression should be considered.
Aims
To investigate relevant outcomes of depression treatment in
specialist care from patients’ and clinicians’ perspectives and to
investigate whether these perspectives differ from each other.
Method
Three focus groups with 11 patients with depression and seven
semi-structured interviews with clinicians were conducted
exploring their perspectives on remission. All interviews were
audio-recorded and transcribed verbatim. We analysed the
transcripts thematically using the phenomenologist approach.
Results
Independently, both patients and clinicians perceived the fol-
lowing outcomes relevant: restoring social functioning and
interpersonal relations, regaining quality of life and achieving
personal goals. All clinicians emphasised symptom reduction
and satisfaction with treatment as relevant outcomes, whereas
the former was not an obvious theme in patients. Unlike clini-
cians, patients made a clear distinction between treatment
outcomes in first versus recurrent/chronic depression.
Conclusions
Classically defined study outcomes based on symptom reso-
lution only partly reflect issues considered important by patients
and clinicians in specialist depression treatment. Incorporating
patients’ and clinicians’ perspectives in the development of
measurable end-points makes them more suitable for use in
trials and subsequent translation to clinical practice.
Furthermore, evaluating patients’ perspectives on treatment
outcomes helps in the development of tailored interventions
according to patients’ needs.
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Evaluation of depression treatment effectiveness may be less
straightforward compared with other medical conditions. Multiple
definitions are used, for example remission, response or recovery
from depression, and inconsistencies within definitions exist.1–3
Remission is widely recognised as themost favourable outcome of
treatment for depression and primarily relies on changes in the
amount and severity of depressive symptoms.4,5 In clinical trials,
depressive symptoms are measured by clinician-rated or patient-
rated depression rating scales, which is a pragmatic way to determine
treatment effects. Although the use of symptom rating scales is
important for objectively measuring treatment outcomes, this
might not be optimal in the case of depression. First, clinical trials
often use treatment outcomes defined by researchers and the clinical
community,6,7 instead of reflecting patients’ values regarding relevant
treatment outcomes.8 Second, depression is a mental disorder with a
high probability of recurrence and chronicity.9 In specialist mental
healthcare, around 85% of patients with major depressive disorder
experience a recurrence within 15 years.10 In those patients, remission
might not be a realistic treatment outcome but would rather be an
exception. Indeed, many remitted patients continue to experience
ongoing deficits in functioning or quality of life.11,12
Symptom-based scales will likely remain the standard for treat-
ment outcome assessment in randomised controlled trials and clin-
ical practice. However, it may be worthwhile to develop measures
that assesses relevant domains other than symptom resolution.13
Incorporating patients’ perspectives and attitudes towards health
and illness, and taking amore patient-centred approach in the assess-
ment of treatment outcomes has gained greater interest recently.
Relevant outcomes of treatment
Patients, their spouses and the community demand treatment that
produces relevant outcomes, i.e. significant return on investment.14,15
Patients that actively engage in treatment decisions have higher satis-
faction scores and better clinical outcomes.16,17 Assessment of treat-
ment effects may be biased if it is based on treatment outcomes that
have limited relevance to patients and clinicians in the consulting
room, having a negative impact on policy decision-making.
Little evidence is available about what patients in specialist
mental healthcare who have experienced depression would define
as relevant outcomes of treatment. A study performed in primary
care demonstrated that patients value a broad range of indicators
of recovery from depression, for instance, managing the depression,
functioning as before and enjoying activities as before the depres-
sion.18 In a quantitative study, patients perceived symptom reso-
lution as only one important factor. The presence of features of
positive health (for example optimism), a return to one’s usual
level of functioning, and feeling like your usual self, were, according
to patients, better indicators of remission from depression.5 Finally,
two studies investigating relevant treatment goals showed that
improvements in functioning in social and occupational domains
were also considered important.19,20
To be able to develop treatments that are in line with patients’
needs and to provide effective specialist depression care, it is
crucial to know what patients value as relevant outcomes of depres-
sion treatment in specialist depression care. In addition, it is import-
ant to know what clinicians perceive as relevant outcomes of
treatment for their patients. Discrepant views may well bring out
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diverging expectations, leading to disappointment and treatment
failure, unnecessary prolongation of treatment or treatment discon-
tinuation. To our knowledge, clinicians’ perspectives on relevant
outcomes of depression treatment have not been explicitly studied
before. The aims of the study are (a) to investigate patient-relevant
outcomes and clinician-relevant outcomes of depression treatment,
and (b) to investigate whether any discrepancies exist between
patients’ and clinicians’ views regarding these relevant outcomes.
Method
Data for this qualitative study were collected by means of focus
group interviews to stimulate exchange of views and experiences
between patients. Due to their time constraints, we conducted
semi-structured interviews with clinicians.
Ethical aspects
In line with the Dutch Medical Research involving Human Subjects
Act, the Medical Ethics Review Board (METc) of the University
Medical Center Groningen exempted this research from full
review. A waiver from the METc was obtained because there was
not an infringement of the physical and/or psychological integrity
of the participants. Prior to the start of the focus groups, written
informed consent was obtained from all participants. All partici-
pants agreed on audiotaping the interviews and usage for scientific
research after anonymisation.
Selection of participants
Both patients and clinicians in the specialist mental healthcare setting
were selected by purposive sampling. Patients were eligible for par-
ticipation in the study if they (a) have (or had) a depressive disorder
as main diagnosis; (b) had experience with depression treatment, and
(c) were willing to share their views and experiences on relevant treat-
ment outcomes for depression treatment in a focus group.
Clinicians were eligible for participation in the study if they (a)
treat(ed) patients with depressive disorders, and (b) were willing to
share their views on relevant treatment outcomes for depression
treatment in a semi-structured interview.
Recruitment of participants took place in the mental healthcare
organisations connected to the Rob Giel Research center (RGOc; a
collaboration of six regional mental healthcare providers in the
Northern-Netherlands). Patient Councils of thesemental healthcare
organisations distributed flyers in waiting rooms and day care areas.
The call was also posted on the RGOc website (www.rgoc.nl) and
distributed via the RGOc newsletter. Clinicians were recruited via
the RGOc network, RGOc website and RGOc newsletter.
Interested participants could sign-up by sending an email or by tele-
phone. One of the researchers (K.K.) approached all participants by
telephone for an eligibility check and asked them via snowball sam-
pling for the recruitment of other potential participants.
In total 18 individuals were eligible: 12 patients and 7 clinicians.
One eligible patient dropped out of the study as he forgot to attend
the focus group meeting.
Data collection
We conducted four focus group interviews in three focus groups
between November 2016 and June 2017. During the first interview,
which was a pilot, we were unable to discuss all the topics of the
interview guide. Therefore, these participants were interviewed a
second time to discuss the undiscussed topics of the interview
guide and to verify the results of the first interview.
The focus group interviews with patients were moderated by F.J.
(PhD, psychologist and epidemiologist) and K.K. (MSc, health sci-
entist). Both researchers are women and have previous experience
and training in conducting and executing qualitative research.
The researchers did not know the participants in advance nor did
they have a therapeutic relationship with the patients. Therefore,
a short introduction round took place prior to the start of the
focus group interviews. The researchers went openly into the
focus group interviews.
The interview guide for the focus group interview was pilot
tested with the first focus group after which we made small adapta-
tions. Topics in the interview guide included: personal experiences
with treatment for depression and treatment goals, used outcomes
during treatment, views on the definition of remission/treatment
success for treatment evaluation.
The focus group interviews with patients took place in ameeting
room in a mental healthcare organisation that was closest to where
the patients lived. Besides participants and researchers, no one else
was present during the focus group interviews. The number of par-
ticipants in the focus groups varied between three and five.
Seven semi-structured interviews with clinicians were con-
ducted by K.K. in May and June 2017. The interview guide for
the semi-structured interviews included the same topics as the
interview guide used for patients. The semi-structured interviews
with clinicians took place in the consulting room of the practising
clinician.
During the (focus group) interviews,wemade field notes and ana-
lysed those as preparation for the next interview. The duration of the
focus group interviews and semi-structured interviews ranged
between 73 and 86 min and between 40 and 85 min, respectively.
We continued with data collection until data saturation was reached.
Data analysis
All focus group interviews and semi-structured interviewswere audio-
taped and transcribed verbatim.Wemade a summary of all interviews
and returned the summaries to the participants for a member check.
We used the phenomenology approach to examine participants’ sub-
jective experiences on a particular phenomenon. Data were coded
using thematic content analysis. Two interviews were open coded
by two researchers (K.K. and F.J.) with paper and pencil for compari-
son. After comparison and agreement on the codes, all transcripts
were coded using the software package ATLAS-ti version 8.0.40.0
(ATLAS.ti Scientific Software Development GmbH) to ensure sys-
tematic coding of the data. Subsequently, main themes were derived
from the data and identified from the codes. Finally, we integrated
main themes and research data to compare patients’ perspectives
and clinicians’ perspectives using the one-sheet-of-paper approach.21
Quotations from the participants were translated from Dutch by a
native English speaker and are presented to illustrate the themes
and findings. See supplementary material (available online at
https://doi.org/10.1192/bjo.2020.27) for the consolidated criteria for
reporting qualitative research checklist that was used to report this
research.
To ensure validity of the study data, peer debriefing took place
on a frequent basis with a third researcher, M.A.A. (PhD, social sci-
entist). From the start of the study (prior to data collection), during
data collection, coding of the data and reporting of the findings, this
unbiased researcher provided feedback to ensure credibility.
Results
Table 1 presents the characteristics of the study sample. Out of 11
patients, 8 patients were women. The patients ranged in age from
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22 to 69 years. Nine patients were currently in treatment for their
depression. Two patients were currently not in treatment and
were in remission and/or had finished treatment at the time of
the focus group interview. Most patients experienced multiple
depressive episodes.
Six clinicians were women and one was a man. They ranged in
age from 32 to 64 years. The clinicians worked in five different
mental healthcare organisations. We interviewed four psychiatrists,
one specialised psychiatric nurse and two psychologists.
Patients’ perspectives on relevant treatment outcomes
in depression treatment
Main themes that emerged from the analysis of the data, relating to
relevant treatment outcomes from the patient’s perspective, are
described below and examples of quotes for each theme are illu-
strated in Table 2.
Social functioning and interpersonal relationships
The majority of patients mentioned goals related to social function-
ing (defined as an individual’s ability to perform and fulfil normal
social roles22) and interpersonal relationships as important goals
of depression treatment. Normalisation of social functioning was
considered important (Table 2, quote 1). It included getting out of
bed, continuing normal daily activities and functioning as before
the depression. One patient stated that it was acceptable to use anti-
depressant medication, if necessary, for obtaining normalisation of
social functioning (Table 2, quote 2). Patients saw undertaking
activities again with friends and family as a good indicator of
social functioning.
However, patients who had experienced multiple depressive
episodes or patients who were diagnosed with chronic depression
had a different view on functioning. They stressed that they
needed to find new ways of functioning they would consider as sat-
isfactory given circumstances, even though it would not quite be in
the same way as before, as illustrated in the next quote:
‘You can also find other ways, can’t you? Functioning very dif-
ferently from how you used to, and yet, um, find satisfaction.
That you’ve found a new mode, let’s say. So you could still
have symptoms, but you have improved as it were.’
(Participant 13, woman, age 41)
Table 1 Characteristics of interviewed patients and clinicians
Patients Clinicians
n 11 7
Mean age, years (s.d.) 43.9 (14.6) 48.4 (13.6)
Male gender, n 3 1
Highest attained educational level, n
High school 3 –
Vocational education 1 –
Bachelor degree 6 –
Master degree 1 –
Household status, n
Single, no child(ren) 4 –
Singe, with child(ren) 1 –
Cohabiting/married, no child(ren) 2 –
Cohabiting/married, with child(ren) 4 –
Depression as main diagnosis, n 11 –
Currently in treatment, n 9 –
Position, n
Specialised psychiatric nurse – 1
Psychologist – 2
Psychiatrist – 4
Work experience, years: mean (s.d.) – 16.6 (14.3)
Table 2 Quotes for each theme from the patient’s perspective
Themes Quotations for illustration
Social functioning and interpersonal
relationships
Quote 1: ‘So the client’s own picture of themselves [how the client themselves feels that they function], but also how
those around them feel that they function. Because I think that’s what’s most important, if you can function more
or less normally, like you used to.’ (Participant 12, man, age 52)
Quote 2: ‘I was finally functioning without medication, and I thought that was fine. It is fine until another bump comes
along and then you start all over again. If I ask myself now; I just want to be able to function again and, if necessary,
with medication, like I did a few years ago. For me, that’s my recovery.’ (Participant 3, man, age 52)
Prevention of future recurrences Quote 3: ‘If you’ve been given um, enough things to hold on to to pull yourself up at times when you are sinking.
Learning to recognize and know what you have to do about it. Identifying and tackling it.’ (Participant 17, woman,
age 25).
Quote 4: ‘Another way of dealing with it…, is to be able to relate success to your ability to deal with a setback
yourself. Without having to go straight back into treatment or taking more pills, that when there are setbacks, a
hard day, which in the past would have sent you straight into the abyss, now you have learned, first I have to do
this and then I have to do that and watch out for this and so on…’ (Participant 1, man, age 60)
Acceptance of illness and managing the
depression
Quote 5: ‘During my first depressive episode, I really wanted things to be just like they were before. Although I did
think that that would never happen, it was in fact my one sole wish. And, um, well, it’s turned out be very different
now from before, but better actually. But it was, it’s been quite a process to accept things and to make
adjustments.’ (Participant 13, woman, age 41)
Quote 6: ‘I see recovery as learning to deal with your situation and to keep going. Because it will never make me
better. And that has determined, and still determines, how I live my life and how I deal with my disabilities, what I
do and what I don’t do. Those are two aspects that the… um, come back every day. What do I do and what do I
forget about? That’s what, that’s what it actually boils down to.’ (Participant 16, woman, age 69).
Personal goals and societal
expectations
Quote 7: ‘That you go shopping, go to work and have a social life, and that this can be too much for people, or whether
your goals is in fact that you can at least have a social life again, or just go to work, that can differ from one client to
the next. But the outside world says, you’re not really part of things again unless you’re working, and that’s what I’d
really like to do.’ (Participant 3, man, age 52).
Quote 8: ‘There is, for example, another goal that I have: in my contact with others I want to be less troubled by certain
things, but that’s not the same as not having any symptoms any more. And in my view, a practitioner often tends
to look from that perspective, if things are x and y, then z is automatically the case, whereas it isn’t always like that.
Sometimes I can feel really good.’ (Participant 2, woman, age 22).
Quote 9: ‘For almost everyone I can think of an example, with all the questionnaires [routine outcome monitoring
questionnaires/symptom rating scales] that you have to fill in, that at some time they say, oh, you’re doing a lot
better, and that you definitely don’t feel that yourself. So um, that’s not the whole story.’ (Participant 1, man, age 60)
Relevant treatment outcomes in depression
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Over one-third of the patients mentioned that their depression
severity and stage of life determined their treatment goals related to
functioning: young patients strived for returning to a full life, such
as being part of the labour force, starting a family, having life goals
like any other person, whereas middle-aged patients adjusted their
goals and ambitions. They focused especially on personal relation-
ships and functioning well within their family again. Being ‘free of
depressive symptoms’ was not mentioned by any patient as a rele-
vant treatment goal when patients experienced recurrent depression
or became chronically depressed.
Prevention of future recurrences
More than half of the patients mentioned that they perceived long-
term outcomes of depression treatment as very meaningful. They
considered it important to learn how to integrate techniques on
how to cope with depression in daily life and to obtain skills for
the prevention or early signalling of future depressive episodes
(Table 2, quote 3 and 4).
Acceptance of illness and managing the depression
As a result of patients experiencing several depressive episodes and
remaining vulnerable, it appeared that accepting that depression is
part of a patient’s life was a way forward. One could still have a good
life, and managing the depression became a goal in half of the inter-
viewed patients as illustrated in the following quote and in Table 2
(quote 5 and 6).
‘…At some point you start to adjust your expectations and at
some point you also realize okay well, in three years’ time I’d
like to be here and here, what do I have to do to achieve
that? And that’s what I’ve more or less achieved and now I
also think, okay and I’ll never be entirely rid of it and I’ll con-
tinue to have that vulnerability.’ (Participant 2, woman, age 22)
Achievement of personal goals and societal expectations
The majority of patients had personal goals that were set during their
depression treatment, for example improving self-esteem, absence of
suicidal thoughts, not being a burden to others, or structure in daily
routine. One-third of the patients mentioned that their own expecta-
tions and goals changed after experiencing several depressive epi-
sodes, realising that full recovery is not attainable.
Some patients experienced societal pressure during treatment.
They felt that their treatment goals were not always in line with
those set by the treating clinician, mental healthcare organisation
or society, as illustrated by quote 7 and 8 in Table 2. Finally, some
patients got the impression that clinicians focused too much on
having no residual symptoms as the clinical end-point, and that
clinicians relied too much on depression severity scales, without
looking at the individual patient (Table 2, quote 9).
Clinicians’ perspectives on relevant treatment
outcomes in depression treatment
Main themes identified from the clinician’s perspective are
described below and illustrated in quotes for each theme in Table 3.
Symptom reduction/clinical improvement
All clinicians mentioned symptom reduction or clinical improve-
ment as an important treatment outcome in practice. They focus
specifically on the main symptoms of depression: low mood, loss
of pleasure in activities and concentration. In addition, the major-
ity of clinicians also use depression severity rating scales to
Table 3 Quotes for each themes from the clinician’s perspective
Themes Quotations for illustration
Symptom reduction/clinical
improvement
Quote 1: ‘The aim in fact is to always have an improvement in the symptoms. Usually measured by means of a
questionnaire but also from a clinical point of view and what the patient tells you.’ (Participant 6, woman, age 37)
Quote 2: ‘There are of course a number of symptoms that you look at. Um, both in mood and in activity, and in sleeping
and eating and restoring contacts and, um, a reduction in anxiety. Um, so in fact you include all symptoms. You can
do this using all sorts of questionnaires [measurement scales]. But this often brings you to a medical history and
consultation, which can provide a lot of information.’ (Participant 8, woman, age 53)
Social functioning and interpersonal
relationships
Quote 3: ‘Of course, you watch out for things: has someone become more active? Have they taken up their roles, their
social and personal roles again? That’s what we focus on in practice. So it’s not just clinical, but, um, simply,
“I notice I can take my child to school again.” “I’m getting up at 8 o’clock again.” “I have started running again.”’
(Participant 4, woman, age 60).
Quote 4: ‘And as to whether or not you should go back to work, well, I’m not society, but I think it would very good if
someone has a network again, that they have some form of social contact that goes a little further than the cashier at
the grocery store, that someone builds up a network again, that people don’t just think…, they take their pills and the
worst is over, no, you also have to ensure that that things continue to go well, because it’s an illness that’s very chronic.
And that’s the biggest danger, that you’re satisfied too soon. And that you therefore have to say to people, you have
keep going or something like that, but that you have to consider that every time.’ (Participant 10, woman, age 59)
Patient satisfaction and quality of life Quote 5: ‘Yeah, through a reduction in symptoms. And of course you also still have quality of life.’ (Participant 4,
woman, age 60)
Quote 6: ‘That you take as a guide: are you happy about it and have you achieved your goals?’ (Participant 9, woman, age 32)
Quote 7: ‘At a certain point during treatment you simply notice that someone, um, and that it’s actually been stable for quite
some time. That the remission, um, you’ve had the remission for several weeks. That they themselves also come across
differently and say that things are going well.’ (Participant 7, woman, age 34)
Achievement of predetermined
personal goals
Quote 8: ‘I look at the level of symptoms, but I also look at whether someone has achieved their goals, um … So you
really look at, what does someone want, what do they want, we try to make goals as specific as possible, in other
words, what does someone want to change and to have achieved? And I then include that and we then do an
evaluation. [the example cited is:] for example, I want to start exercising once a week again, it could be. Or someone
says, I want more peace in my mind. Well, you have to make that more specific of course. Um, very often it involves
picking up certain things again or doing less. Um, or fewer negative thoughts, thinking more positively about myself,
those kind of things.’ (Participant 7, woman, age 34)
Quote 9: ‘You draw up a treatment plan. And in the treatment plan, yeah, you indicate what you, what you in fact, what
you want to achieve. Ideally, um, the objective should be achieved. Or in any case, um, should offer good prospects
of being achieved.’ (Participant 5, man, age 64)
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evaluate symptom reduction or clinical improvement (Table 3,
quote 1 and 2).
Social functioning and interpersonal relationships
All clinicians mentioned that patients should be able to take up
former social and personal roles, as illustrated in the following
example and quote 3 in Table 3.
‘That it gradually improves in terms of mood, that the level of
activity improves, do they go back to school or not, do they
start a course, do they leave the house, sometimes it’s …, it
depends how serious it is, to also look at that, not only to
have the symptoms gone but also that they become active
again and, say, resume their normal development somehow
and keep going.’ (Participant 10, woman, age 59)
Participating at work was not seen as a necessary goal of treat-
ment from the clinician’s perspective (Table 3, quote 4).
Patient satisfaction and quality of life
The majority of clinicians noted that quality of life and patient sat-
isfaction with treatment or satisfaction with functioning were also
relevant when determining whether depression treatment was suc-
cessful (Table 3, quote 5, 6 and 7). More than half of the clinicians
mentioned that they ask whether their patients are satisfied with the
results of treatment.
Achievement of predetermined personal goals
Most clinicians mentioned that achieving goals defined at the start of
the treatment was a relevant indicator of treatment success (Table 3,
quote 8). According to clinicians, these predetermined goals mainly
relate to personal goals and may differ between patients, but should
preferable be agreed upon by patient and clinician. One clinician
mentioned that it would be helpful to base treatment success on
achievement of predetermined treatment goals, as it is hard to tell
whether a patient is in full remission (Table 3, quote 9).
Similarities and discrepancies between patients’ and
clinicians’ perspectives
In Table 4 relevant outcomes according to both perspectives are
summarised. Restoring social functioning and interpersonal rela-
tions, regaining quality of life, and achieving personal goals were
mentioned most often as important indicators of treatment
success by both clinicians and patients. In the last column of the
table, we have added outcomes that are frequently used in rando-
mised controlled trials for comparison with the outcomes in our
study.1,2 Apparently, in trials reduction of symptoms, i.e. (time to)
recovery, remission, response, or a functional/administrative
outcome are considered relevant outcomes.
Importantly, evident discrepancies between clinicians’ judge-
ments and patients’ perspectives also emerged. Clinicians empha-
sised symptom reduction as a relevant treatment outcome,
whereas for patients this was not a prominent theme. Although nor-
malisation of social functioning and interpersonal relationshipsmay
go hand in hand with symptom reduction, some patients argued
clinicians focused too much on being free of symptoms, whereas
patients would rather learn how to manage their depression. Next,
only patients and not clinicians made a clear distinction between
treatment outcomes in a first-episode of depression versus recur-
rent/chronic depression. Notably, clinicians mentioned patient
satisfaction with treatment as a relevant outcome in the treatment
of depression.
Discussion
Main findings and comparison with findings from other
studies
This qualitative study provides new insights into what patients and
clinicians perceive as relevant outcomes in the treatment of depression
in the specialist care setting. From a patient’s perspective, the main
themes identified were social functioning and interpersonal relation-
ships, prevention of future recurrences, managing depression and
achieving personal goals. Clinicians on the other hand were mainly
focused on symptom reduction and clinical improvement, social func-
tioning and interpersonal relationships, patient satisfaction and
achievement of predetermined personal goals. Patients and clinicians
agreed on the majority of issues, but differences were also found.
Importantly, usual end-points defined in trials, i.e. remission and
response, only to a limited extent appear to reflect what matters in
clinical practice. This may indicate that the efficacy observed in
trials may not reflect actual preferences, which in turn results in dis-
appointment with treatment effects. The focus group interviews
undeniably demonstrated that patients perceived other outcomes
relevant in addition. Especially after experiencing several depressive
episodes, patients adapt their treatment goals. Our results indicate
that we may need to use different end-points when treating a first
episode versus recurrent or chronic depression, so that treatment






Most used outcomes in randomised
controlled trials
Symptom reduction/clinical improvement ✓a ✓ ✓
Social functioning ✓ – –
Managing the depression ✓ – –
Acceptance of the depression ✓ – –
Absence of future recurrences/obtain skills for relapse prevention ✓ – –
Achievement of personal goals ✓ ✓ –
Patient satisfaction with treatment – ✓ –
Maintenance quality of life ✓ ✓ –
Statistical tests – – ✓
Time to recovery – – ✓
Cut-off score on depression rating scale (remission) – ✓b ✓
% change on depression rating scale (response/recovery) – ✓b ✓
Functional criteria (for example hospital discharge or admission,
change in assigned treatment)
– – ✓
✓, present.
a. ‘Functioning as before’.
b. Results depression rating scales + clinical judgement.
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goals and success can reflect all stages of the disease.23 To inform
more extensively on clinically relevant results, Rush et al proposed
including a second end-point, such as daily functioning, in clinical
trials in difficult-to-treat depression.24
As in other chronic diseases, patients have reported still experien-
cing a good quality of life despite the fact that they have not fully
recovered or achieved remission, the so called ‘disability paradox’.25
Clinicians on the other hand, emphasised symptom reduction, treat-
ment satisfaction and achievement of predetermined treatment goals,
of which the latter are not generally taken into account in clinical
trials either.
There is an ongoing debate whether the World Health
Organization definition of health, described as ‘a state of complete
physical, mental and social well-being and not merely the absence of
disease or infirmity’26 still fits in a world where chronic diseases are
highly prevalent. Newly proposed definitions suggest including the
ability of people to develop strategies to cope with the disease while
maintaining their perceived quality of life.27 Learning to cope with
depression and learning to function satisfactorily are in line with the
proposed definitions of health, especially in chronic conditions.
By using qualitative methods, patients and clinicians can elabor-
ate freely on what they consider important without being guided by
suggestions from researchers, pre-defined questionnaires or clinical
expectations. Our findings are in accordance with findings from the
few previous studies that were performed on defining recovery from
depression, especially regarding functioning in several domains and
returning to one’s usual level of functioning.5,18–20,28 In addition, we
noted that patients gradually modify their treatment goals after
several reoccurrences, which, as far as we know, has not been
described before. Interestingly, relevant outcomes related to differ-
ent domains of functioning (such as physical, social) are also found
to be important in other disorders (for example heart failure,
diabetes, psychosis).29–31
Limitations
In this study, a few factors should be taken into consideration. First,
most of the interviewed patients had either chronical depression or
had gone through several depressive episodes, which was a
representation of the specialist mental healthcare treatment
setting. In the Netherlands, specialist mental healthcare providers
deliver in-patient, out-patient and community care treatment to
patients with severe mental health problems. In contrast, patients
with mild-to-moderate non-complicated psychiatric disorders
receive treatment from a general practitioner with additional
support from a specialised mental healthcare nurse. Alternatively,
they may be referred to generalist mental healthcare. Patients with
a single episode only were less represented. However, the patients
in our study that experienced multiple episodes of depression men-
tioned the same relevant treatment outcomes for a first episode as
patients who experienced a single episode only. Our study sample
is likely to be representative for patients in our catchment area.
The ratio of men to women diagnosed with depression is 2:3.
Second, most participants were of White ethnicity. Culture and
ethnicity might have influenced treatment goals deemed relevant in
depression care. Third, within the varied group of clinicians not all pro-
fessions were equally well represented. However, we verified our results
by grouping the type of clinicians and it appeared the results were very
consistent between the professions. Therefore, we think that our
sample of clinicians has provided representative themes, and data sat-
urationwas reached. Finally, a focus group interviewwith both patients
and clinicians might have resulted in more in-depth discussions and
interaction between both views. On the other hand, this could also
have introduced social desirability bias in patients.
Implications
The results of this study are relevant for both research and clinical
practice. Traditional end-points used in clinical trials only partly
reflect factors that are deemed relevant to patients and clinicians
alike. Several outcomes considered relevant by patients and clini-
cians, such as functioning and quality of life, would be relatively
easy to incorporate in outcome assessment for depression, as vali-
dated questionnaires are available. In addition, by developing or
adding questionnaires related to the achievement of personal
goals and patient’s treatment satisfaction, this field would move
even further towards value-based care. The current study therefore
provides relevant input for the further development of patient-
reported outcome measures. The development of such self-reported
instruments necessitates direct input from patients, which is still
broadly disregarded in conventional research.15,32
Likewise, goal-setting appears to be very important for treat-
ment evaluation from both the patients’ and clinicians’ perspectives,
but is barely used in randomised controlled trials to evaluate
treatment. To ensure that patients and clinicians speak the same
language, they should be more explicit in the common goals they
have in mind for treatment. How patients and clinicians can
improve common goal-setting warrants further investigation.
To conclude, in treatment-outcomes research, the focus should
go beyond symptom resolution. Both patients and clinicians value
other outcomes, especially in recurrent or chronic depression.
When treatment efficacy and effectiveness are measured in terms of
value-based end-points, treatment outcomes are more meaningful,
and improvement in treatment success rates becomes achievable.
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